Clinical Trial Update: Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenalidomide, dexamethasone, and elotuzumab with or without cyclophosphamide in relapsed primary amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Elotuzumab (elotuzumab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Recurrent Primary Amyloidosis | Phase 2 | Status: UNKNOWN